Solar A/S
CSE:SOLAR B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Solar A/S
CSE:SOLAR B
|
DK |
|
Red Electrica Corporacion SA
LSE:0RI5
|
ES |
|
C
|
Corporate Office Properties Trust
F:WX7
|
US |
|
Novozymes A/S
CSE:NZYM B
|
DK |
|
John Menzies PLC
LSE:MNZS
|
UK |
|
O
|
Orion Office Reit Inc
NYSE:ONL
|
US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SOLAR B's stock price target?
Not Available
SOLAR B doesn't have any price targets made by Wall Street professionals.
What is Solar A/S's Revenue forecast?
Projected CAGR
5%
For the last 9 years the
compound annual growth rate for
Solar A/S's revenue is
2%.
The projected
CAGR
for the next 3 years is
5%.
What is Solar A/S's Operating Income forecast?
Projected CAGR
30%
For the last 9 years the
compound annual growth rate for
Solar A/S's operating income is
-5%.
The projected
CAGR
for the next 3 years is
30%.
What is Solar A/S's Net Income forecast?
Projected CAGR
49%
For the last 9 years the
compound annual growth rate for
Solar A/S's net income is
-6%.
The projected
CAGR
for the next 3 years is
49%.
